Literature DB >> 19205909

Determination of mutation patterns in human ornithine transcarbamylase precursor.

Shaomin Yan1, Guang Wu.   

Abstract

OBJECTIVE: The ornithine transcarbamylase is a mitochondrial matrix homotrimeric enzyme, whose deficiency is the most common genetic defect of the urea cycle and an X-linked semidominant disorder. To understand its mutation pattern is very helpful for managing its clinical manifest and outcome.
METHODS: The amino-acid pair predictability is used to transfer the symbolized human ornithine transcarbamylase and its 117 missense point mutants to scalar data and classify the amino-acid pairs as predictable and unpredictable in order that we can analyse the mutation pattern in scalar data domain rather than symbol domain.
RESULTS: The results show that the mutation is highly likely to occur at the unpredictable amino-acid pairs, and the mutation has the trend to make an amino-acid pair approach predictable.
CONCLUSION: The results provide insight on mutation from the viewpoint based on random mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205909     DOI: 10.1007/s10877-009-9162-3

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  34 in total

Review 1.  Genetic counseling issues in urea cycle disorders.

Authors:  Lisa Sniderman King; Rani H Singh; William J Rhead; Wendy Smith; Brendan Lee; Marshall L Summar
Journal:  Crit Care Clin       Date:  2005-10       Impact factor: 3.598

Review 2.  Unmasked adult-onset urea cycle disorders in the critical care setting.

Authors:  Marshall L Summar; Frederick Barr; Sheila Dawling; Wendy Smith; Brendan Lee; Rani H Singh; William J Rhead; Lisa Sniderman King; Brian W Christman
Journal:  Crit Care Clin       Date:  2005-10       Impact factor: 3.598

Review 3.  Protein design by directed evolution.

Authors:  Christian Jäckel; Peter Kast; Donald Hilvert
Journal:  Annu Rev Biophys       Date:  2008       Impact factor: 12.981

4.  Describing evolution of hemagglutinins from influenza A viruses using a differential equation.

Authors:  Shaomin Yan; Guang Wu
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

5.  Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype.

Authors:  B A McCullough; M Yudkoff; M L Batshaw; J M Wilson; S E Raper; M Tuchman
Journal:  Am J Med Genet       Date:  2000-08-14

6.  Cross-sectional multicenter study of patients with urea cycle disorders in the United States.

Authors:  Mendel Tuchman; Brendan Lee; Uta Lichter-Konecki; Marshall L Summar; Marc Yudkoff; Stephen D Cederbaum; Douglas S Kerr; George A Diaz; Margaretta R Seashore; Hye-Seung Lee; Robert J McCarter; Jeffrey P Krischer; Mark L Batshaw
Journal:  Mol Genet Metab       Date:  2008-06-17       Impact factor: 4.797

Review 7.  Advances in understanding molecular determinants in FeLV pathology.

Authors:  Laura S Levy
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

8.  Targeting of pre-ornithine transcarbamylase to mitochondria: definition of critical regions and residues in the leader peptide.

Authors:  A L Horwich; F Kalousek; W A Fenton; R A Pollock; L E Rosenberg
Journal:  Cell       Date:  1986-02-14       Impact factor: 41.582

9.  Analysis of mRNA transcripts improves the success rate of molecular genetic testing in OTC deficiency.

Authors:  Katharina Engel; Jean-Marc Nuoffer; Chris Mühlhausen; Vera Klaus; Carlo R Largiadèr; Konstantinos Tsiakas; René Santer; Bendicht Wermuth; Johannes Häberle
Journal:  Mol Genet Metab       Date:  2008-04-25       Impact factor: 4.797

Review 10.  Noninvasive human metabolome analysis for differential diagnosis of inborn errors of metabolism.

Authors:  Tomiko Kuhara
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-03-31       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.